Avelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can Significantly Improve Cancer Detection in Real Time During Breast Cancer Surgery

SAN DIEGO–(BUSINESS WIRE)– #breastcancer–Top-line data showed the planned re-excision rate for patients who underwent breast cancer surgery with pegloprastide was 6% (vs typical rate 20-40%).

Avelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can Significantly Improve Cancer Detection in Real Time During Breast Cancer Surgery

SAN DIEGO–(BUSINESS WIRE)– #breastcancer–Top-line data showed the planned re-excision rate for patients who underwent breast cancer surgery with pegloprastide was 6% (vs typical rate 20-40%).